Search

Repligen Corp

Fermé

SecteurSoins de santé

178.35 1.04

Résumé

Variation du prix de l'action

24h

Actuel

Min

174.22

Max

177

Chiffres clés

By Trading Economics

Revenu

-3.3M

5M

Ventes

9.9M

204M

P/E

Moyenne du Secteur

236.315

48.735

BPA

0.54

Marge bénéficiaire

2.453

Employés

2,000

EBITDA

14M

46M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+15.44% upside

Dividendes

By Acuity

Prochains Résultats

27 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

3.6B

11B

Ouverture précédente

177.31

Clôture précédente

178.35

Repligen Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 oct. 2026, 19:36 UTC

News

Canaccord Genuity raises Repligen Corp's price target to $180.00 from $145.00 while maintaining a Hold rating, reflecting a positive reassessment of the company's value.

16 oct. 2026, 22:01 UTC

Repligen Corp is trading lower in after-market hours, following a notable decline since Friday's close amid unusual volatility and positioning near its one-month range low.

15 oct. 2026, 20:07 UTC

Repligen Corp shares advanced, reaching a peak before the session's conclusion.

14 oct. 2026, 20:07 UTC

Repligen Corp shares are advancing, benefiting from broader market gains, despite pulling back from earlier session highs. The stock is higher since Tuesday's close.

13 oct. 2026, 20:07 UTC

News

Repligen Corp shares are advancing as the company prepares to report its third-quarter 2026 financial results on October 27, 2026.

12 oct. 2026, 21:03 UTC

Repligen Corp shares advanced during after-market hours on Monday, moving from a low return to a high return.

9 oct. 2026, 20:01 UTC

Repligen Corp shares are sharply higher, continuing an upward trajectory since Thursday's close, supported by positive movement in the broader life sciences sector.

8 oct. 2026, 20:07 UTC

Repligen Corp shares fell sharply, continuing a downward trend with three consecutive sessions down, despite a brief recovery earlier in the session.

7 oct. 2026, 20:01 UTC

News

Repligen Corp. finalized its $1.5 billion acquisition of BioLife Solutions, but shares fell sharply amid ongoing declines following a prior session drop.

6 oct. 2026, 21:01 UTC

Repligen Corp's shares traded modestly higher in after-market hours, marking a peak since Tuesday's close despite remaining below the 20-day moving average.

5 oct. 2026, 22:15 UTC

News

Repligen Corp plans to acquire BioLife Solutions, contributing to a modest after-market hours gain as the stock remains above its 20-day moving average.

2 oct. 2026, 20:07 UTC

Repligen Corp's shares are advancing, reflecting a broader market trend, maintaining strong performance above the 20-day moving average amid notable intraday volatility.

1 oct. 2026, 20:02 UTC

Repligen Corp shares fell sharply, breaking a trend of higher daily closes and diverging from recent upward momentum.

30 sept. 2026, 21:01 UTC

Repligen Corp is advancing in after-market trading, reflecting broader market gains amid revised Q2 GDP growth and stronger consumer spending.

29 sept. 2026, 23:25 UTC

Repligen Corp has seen a modest decline in after-market trading, retracing from earlier gains and reflecting unusual volatility compared to Tuesday's close.

28 sept. 2026, 20:07 UTC

Repligen Corp shares are higher today, maintaining an upward trajectory since Friday's close, supported by strong performance in the life sciences sector.

25 sept. 2026, 21:01 UTC

Repligen Corp's shares advanced modestly higher during after-market hours, reflecting strong performance and favorable conditions above their 20-day moving average.

24 sept. 2026, 22:05 UTC

Repligen Corp's shares advanced modestly higher in after-market trading, currently 9.33% above its 20-day moving average and near the upper end of its one-month range.

23 sept. 2026, 23:46 UTC

Repligen Corp's stock declined in after-market trading, hitting its lowest point of the day after Wednesday's close, despite remaining above its 20-day moving average.

22 sept. 2026, 20:13 UTC

Repligen Corp's shares advanced modestly in after-market trading, maintaining strength and staying significantly above its 20-day moving average.

21 sept. 2026, 20:06 UTC

Correlated Moves

Repligen Corp is advancing, supported by sympathy with Agilent Technologies' new product launch, and is performing strongly above its 20-day moving average.

18 sept. 2026, 19:16 UTC

Repligen Corp shares fell modestly, fluctuating between small gains and losses, despite remaining above the 20-day moving average and near the one-month range.

16 sept. 2026, 19:16 UTC

Repligen Corp shares fell after briefly rising, retracing from earlier gains in Wednesday's trading session following three consecutive sessions of increases.

15 sept. 2026, 20:07 UTC

Correlated Moves

Repligen Corp is higher today, moving alongside Revvity Inc amid a broader market decline following a drop in the NY Empire State Manufacturing Index.

14 sept. 2026, 19:46 UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock has fluctuated within a range during the session.

11 sept. 2026, 21:01 UTC

Repligen Corp shares are higher in after-market trading, continuing an upward trend since Friday's close. The stock remains below its 20-day moving average.

10 sept. 2026, 20:07 UTC

Repligen Corp shares are lower amid broader market declines following the European Central Bank's interest rate hike and rising Treasury yields.

9 sept. 2026, 20:07 UTC

Repligen Corp shares are lower during Wednesday's session, with no specific news identified. The stock remains significantly below its 20-day moving average.

8 sept. 2026, 22:21 UTC

Repligen Corp shares declined in after-market trading, falling further from Tuesday's close and remaining near the lower end of their one-month trading range.

2 sept. 2026, 19:26 UTC

Repligen Corp shares are higher during Wednesday's session, reaching a session high earlier today. The stock shows resilience amid broader market geopolitical tensions.

Comparaison

Variation de prix

Repligen Corp prévision

Objectif de Prix

By TipRanks

15.44% hausse

Prévisions sur 12 Mois

Moyen 202.5 USD  15.44%

Haut 225 USD

Bas 180 USD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

9 ratings

8

Achat

1

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat